• 한국신재생에너지학회:학술대회논문집
• /
• 2008.05a
• /
• pp.499-502
• /
• 2008

고정층반응기에서 니켈이 치환된 하이드로탈사이트($Ni_3Mg_3Al_2(CO_3)(OH)_{{16}{\cdot}n}H_2O$ ; n=3$\sim$5)를 합성하고 여기에 세리아를 첨가 후 소성하여 얻은 촉매를 사용하여($Ce_xNi_3$-HTlc ; x=0.3$\sim$1.2) 메탄의 부분산화 반응실험을 수행하였다. 세리아가 첨가되지 않은 촉매는 반응 초기 활성이 세리가가 소량 첨가된 ($Ce_{0.3}Ni_3$-HTlc) 촉매보다 우수하였으나 장시간 반응에서는 차차 활성이 저하되었으나, $Ce_{0.3}Ni_3$-HTlc의 활성은 30시간까지 일정하게 유지 되었다. 세리아 함량이 많아 질수록 촉매 활성은 점차 저하되었으며, $Ce_{1.2}Ni_3$-HTlc 는 촉매활성이 매우 낮았다.

• New & Renewable Energy
• /
• v.4 no.2
• /
• pp.39-44
• /
• 2008

Partial oxidation of methane was carried out by ceria-promoted Ni-substituted hydrotalcite-derived catalysts ($Ce_xNi_3$-HTlc ; x=$0.3{\sim}1.2$) in a fixed-bed reactor. The Ce/Ni ratio of 0.3/3 in the catalyst showed the best catalytic activity but the Ce/Ni ratio became higher above 0.3/3, the catalyst became less active in short-term tests. No ceria promoted catalyst was started to decrease $CH_4$ conversion after 20 h but the Ce/Ni ratio 0.3/3 catalyst was kept its stability in long-term tests.

• Journal of Pharmaceutical Investigation
• /
• v.36 no.3
• /
• pp.193-199
• /
• 2006

A bioequivalence study of $Sudo^{TM}$ Ranitidine HCI tablet (Sudo Pharma. Ind. Co., Ltd.) to $Curan^{TM}$ tablet (Il Dong Pharma. Ind. Co., Ltd.) was conducted according to the guidelines of Korea Food and Drug Administration (KFDA). Twenty four healthy male Korean volunteers received each medicine at the ranitidine hydrochloride dose of 150 mg in a 2x2 crossover study. There was a one week wash-out period between the doses. Plasma concentrations of ranitidine were monitored by a high-turbulent liquid chromatography (HTLC) for over a period of 12 hours after drug administration. $AUC_t$ (the area under the plasma concentration-time curve from time zero to 12 hr) was calculated by the linear trapezoidal rule method. $C_{max}$ (maximum plasma drug concentration) and $T_{max}$ (time to reach $C_{max}$) were compiled from the plasma concentration-time data. Analysis of variance was carried out using logarithmically transformed $AUC_t$ and $C_{max}$. No significant sequence effect was found far all of the bioavailability parameters indicating that the crossover design was properly performed. The 90% confidence intervals of the $AUC_t$ ratio and the $C_{max}$ ratio for $Sudo^{TM}$ Ranitidine $HCl/Curan^{TM}$ were 0.92-1.00 and 0.90-1.03, respectively. These values were within the acceptable bioequivalence intervals of 0.80-1.25. Thus, our study demonstrated the bioequivalence of $Sudo^{TM}$ Ranitidine HCI and $Curan^{TM}$ with respect to the rate and extent of absorption.

• Journal of the Korea Institute of Information Security & Cryptology
• /
• v.29 no.1
• /
• pp.187-194
• /
• 2019

Ever since the world's largest Bitcoin Echange, (Mt. Gox), was closed in March 2014 due to the series of hacking, still many other Exchages incl. recent Coinale in Korea have been attacked. Those hacking attempts never stopped and have caused significant threats to the overall industry of Crypto Currency and resulted in the loss of individual investors' asset. The DEX (Decentralized Exchange) has been proposed as a solution to fix the security problem at the Exchange, but still it is far away to resolve all issues. Therefore, this paper firstly analyzes security threats against existing Crypto Currency Exchanges and secondly derives security requirements for them. To do that it proposes a secure and distributed Crypto Currency Transaction Model through Personal Security devices as a solution. The paper also proves this new attempt by demonstrating its unique modelling; ultimately by adopting this modeling into Crypto Exchange is to avoid potential security threats.

• Journal of Pharmacopuncture
• /
• v.15 no.4
• /
• pp.52-65
• /
• 2012

Objectives: Toad venom, called Chan-Su, is a traditional Oriental medicine secreted from the auricular and the skin glands of the Bufo bufo gargarizanz Cantor or B. melanosticus Schneider and has been widely used in China, Korea and other parts of Asia for the treatment of pain, heart conditions, and cancer. We examined the concentrations of the main chemical constituents within a commercially available toad venom product and compared the levels for different extraction methods. Methods: Toad venom was extracted using either cold or hot water, ethanol (EtOH), methanol (MeOH), or ethyl acetate (EtOAc), was fractionated using precipitation or reflux, and was then analyzed using thin layer chromatography (TLC), high-performance liquid chromatography (HTLC), and liquid chroma-tography - mass spectrometry (LC-MS). Individual components were identified by comparisons of the retention times, the ultraviolet spectra, and mass spectras and differences in chemical constituents for different solvents and extraction methods are presented. Results: Components with authentic standards, including serotonin and bufodienolides (cinobufagen, bufalin, cinobufalin, and resibufogenin), were detected. The water extract of toad venom contained the greatest amount of serotonin ($75.7{\pm}0.1$ mg/g), but very small amounts of bufodienolides ($3.8{\pm}0.0$ mg/g). In contrast, the use of MeOH or EtOH extraction solutions resulted in 5-26 times higher concentrations of bufodienolides, with only trace amounts of serotonin. The relative and the absolute concentrations of the component also varied based on the extraction method; i.e., EtOH extracts yielded the greatest total amounts of bufodienolides, and EtOAc precipitation had the lowest amounts of bufodienolides. Conclusions: Toad venom consists of serotonin and several bufodienolides, and the choice of solvent to extract chemical the constituents is important as a way to enrich the purported active components for treating different conditions.